Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sale Of Australia's HeartWare To Thoratec Of U.S. Canceled

This article was originally published in PharmAsia News

Executive Summary

Australia's HeartWare International, maker of medical devices, may not be sold soon after all. The U.S. Federal Trade Commission indicated it would challenge the purchase, leading Thoratec to cancel the deal. The firm's CEO said the board decided not to pursue a deal it figured would be protracted, costly and unpredictable. The FTC was concerned the merger of the two companies would lead to a monopoly of the market for left ventricular assist devices, which are used in patients with advanced heart failure. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts